Heron Therapeutics (HRTX) Announces 16.13M Share Private Placement at $3.10/sh Aug 9, 2022 08:01AM
Heron Therapeutics Announces $76.5 Million Private Placement Financing Aug 9, 2022 08:01AM
Veru (VERU) and Opiant (OPNT) Top Cantor Fitzgerald's List of Largest Short Interest Increases Apr 27, 2022 05:55AM
Heron Therapeutics (HRTX) and Omeros (OMER) Top Cantor Fitzgerald's Most Shorted List; Clarus (CRXT) and United Therapeutics (UTHR) Seeing Biggest Short Interest Increases Apr 12, 2022 05:53AM
UPDATE: HUTCHMED (China) (HCM) and Viatris (VTRS) Top Cantor Fitzgerald's List of Biggest Short Interest Increases, Heron (HRTX) and Omeros (OMER) Continue to Have Higher Short Floats Mar 28, 2022 11:10AM


Mar 10, 2022 05:45AM Heron Therapeutics (HRTX) and Omeros (OMER) Top Cantor Fitzgerald's Most Shorted List; Amgen (AMGN) and PDS (PDSB) Seeing Biggest Increases
Mar 1, 2022 07:22AM Heron Therapeutics (HRTX) PT Lowered to $20 at Cantor Fitzgerald
Jan 12, 2022 06:24AM Heron Therapeutics (HRTX) and Omeros (OMER) Top Cantor Fitzgerald's Most Shorted List
Dec 28, 2021 05:55AM VYNE Therapeutics (VYNE) and Ardelyx (ARDX) Top Cantor Fitzgerald's Most Shorted Biotech List
Jul 29, 2021 06:46AM Companies with NDRs 7/29
May 13, 2021 11:34AM Heron Therapeutics (HRTX) Approval 'Positive, Even Without The Cherry on Top' - Cantor Fitzgerald
Jun 29, 2020 11:45AM Heron Therapeutics (HRTX) PT Lowered to $26 at Cantor Fitzgerald, After Receiving Complete Response Letter for HTX-011
Feb 20, 2020 07:14AM Cantor Fitzgerald Reiterates Overweight Rating on Heron Therapeutics (HRTX)
Oct 1, 2019 09:41AM Heron Therapeutics (HRTX) HRX-011 Resubmission a 'Significant Positive' - Cantor Fitzgerald
May 1, 2019 04:15PM Heron Therapeutics (HRTX) PT Lowered to $41 at Cantor Fitzgerald
Jan 2, 2019 07:18AM Cantor Fitzgerald Remains Bullish on Heron Therapeutics (HRTX) Following NDA Acceptance
Sep 27, 2018 08:22AM Heron Therapeutics (HRTX) Defended at Cantor
Jul 19, 2018 07:06AM Heron Therapeutics (HRTX) PT Raised to $50 at Cantor Fitzgerald
Jun 21, 2018 10:47AM Two More Positive HTX-011 Studies Supports Bullish Heron Therapeutics (HRTX) Thesis - Cantor Fitzgerald
Mar 19, 2018 12:18PM Heron Therapeutics (HRTX) PT Raised to $40 at Cantor Fitzgerald
Dec 5, 2017 09:02AM Heron Therapeutics (HRTX) Prices $150M Common Stock Offering
Dec 5, 2017 09:00AM Heron Therapeutics Announces Pricing of Public Offering of Common Stock
Dec 4, 2017 04:01PM Heron Therapeutics (HRTX) Plans Public Offering of Common Stock
Dec 4, 2017 04:01PM Heron Therapeutics Announces Public Offering of Common Stock
Sep 18, 2017 04:05PM Heron Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference
Aug 18, 2017 06:07AM Cantor Fitzgerald Assumes Heron Therapeutics (HRTX) at Overweight
May 12, 2017 06:54AM Heron Therapeutics (HRTX) PT Raised to $31 at Cantor Fitzgerald
Feb 27, 2017 06:52AM Heron Therapeutics (HRTX) PT Lowered to $30 at Cantor Fitzgerald Following $167.3M Capital Raise
Jan 19, 2017 06:34AM Heron Therapeutics (HRTX) Prices Offering at $12.20/Share
Jan 19, 2017 06:30AM Heron Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock
Jan 5, 2017 06:43AM Heron Therapeutics (HRTX): Sustinol Trumps Positive HTX-011 Data - Cantor
May 3, 2016 08:27AM Cantor Fitzgerald Starts Heron Therapeutics (HRTX) at Buy